DAVID LEVITT
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism HANOVER, MD NPI 1497020564
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MD Abbott Laboratories All categories
General Payments — all program years on this page
$7,022.23
- Category: General Payments
- Program years: PY2018–2024
- Record count: 161
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,633.54 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,356.25 | 3 |
| Food and Beverage | $1,139.79 | 56 |
| Consulting Fee | $1,137.50 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $3,589.91 | 12 |
| Lilly USA, LLC | $307.87 | 15 |
| SANOFI-AVENTIS U.S. LLC | $78.56 | 3 |
| Corcept Therapeutics | $73.75 | 4 |
| ABBVIE INC. | $64.58 | 3 |
| Radius Health, Inc. | $55.53 | 2 |
| Antares Pharma, Inc. | $52.73 | 2 |
| DEXCOM, INC. | $48.92 | 2 |
| Amneal Pharmaceuticals LLC | $46.41 | 3 |
| Novo Nordisk AS | $45.03 | 2 |
| Amgen Inc. | $41.99 | 2 |
| Alexion Pharmaceuticals, Inc. | $35.87 | 2 |
| Ultragenyx Pharmaceutical Inc. | $24.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.72 | 1 |
| BETA BIONICS, INC. | $22.66 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.25 | 1 |
| CeQur Corporation | $19.23 | 1 |
| Tandem Diabetes Care, Inc. | $18.57 | 1 |
| Medtronic, Inc. | $18.05 | 1 |
| Amphastar Pharmaceuticals, Inc. | $17.51 | 1 |
| TOLMAR, INC. | $13.79 | 1 |
| Currax Pharmaceuticals LLC | $13.24 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.